1982
DOI: 10.1016/0014-5793(82)80228-7
|View full text |Cite
|
Sign up to set email alerts
|

Allosteric changes of the guanine nucleotide site of elongation factor EF‐Tu

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
11
0

Year Published

1982
1982
1999
1999

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 18 publications
(31 reference statements)
2
11
0
Order By: Relevance
“…EF-Tu (Lb) has a considerably higher affinity than EF-Tu (Ec) for GTP. In this respect, the protein is similar to that of kirromycin-resistant mutants of E. coli [16]. …”
Section: Heat Stabilitymentioning
confidence: 72%
“…EF-Tu (Lb) has a considerably higher affinity than EF-Tu (Ec) for GTP. In this respect, the protein is similar to that of kirromycin-resistant mutants of E. coli [16]. …”
Section: Heat Stabilitymentioning
confidence: 72%
“…It is germane to mention that in the absence of effectors influencing its interaction with GDP/GTP, the initial rate of the singleturnover GTPase of EF-Tu-GTP (0.06 mmol of GTP hydrolyzed per sec per mol of EF-Tu) is very close to the rate of the multiple-round GTPase of the G domain (see above). In the case of EF-Tu the multiple turnover hydrolysis is strongly inhibited by the tightly bound product GDP (28,29). The absolute specificity of EF-Tu for guanine nucleotides is conserved in the G domain; no detectable ATPase activity was found when tested using [y-32P]ATP of very high specific activity (data not shown).…”
Section: Resultsmentioning
confidence: 97%
“…The evidence available shows that mutant factors resistant to factortargeted drugs may differ from susceptible factors merely by one amino acid. In fact, substitutions of alanine at position 375 within the allosterically important kirromycin-binding domain of E. coli EF-Tu result in kirromycin resistance (19). We note, however, that the basic phylogenetic stability of the drug-sensitive phenotype within the eubacterial kingdom indicates that the site involved in kirromycin binding is subject to severe selective constraints.…”
Section: Resultsmentioning
confidence: 80%